Uniscept(Tm)
by Analytical Products, Inc. PMA
Active
PMA P830028
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP830028 | Date9 Mar 1984 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- Generic Name
- Manual antimicrobial susceptibility test systems
- PMA Number
- FDA Product Code
- JWY
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1640
- Advisory Committee
- Microbiology
- FDA Decision
- APPR Approved
- PMA Supplement
- S001
Overview
AI-generated summary, 18 Sep 2026
The Uniscept Manual Antimicrobial Susceptibility Test System is a Manual antimicrobial susceptibility test system, designed for microbiological testing to determine bacterial sensitivity to antimicrobial agents. It facilitates the evaluation of bacterial isolates against a range of antibiotics, aiding in the selection of appropriate treatment regimens for infectious diseases.
This system is supplied as a manual test kit and is intended for use in clinical microbiology laboratories. It is classified as a Class II device under FDA regulations (866.1640) and requires sterile components for accurate results. The system is regulated under FDA PMA (P830028) and is distributed in configurations matching product codes such as JWY, ensuring compliance with microbiological testing standards.
Other devices from Analytical Products, Inc.
Questions
AI-generated answers, 18 Sep 2026
What types of bacterial isolates can the Uniscept™ system test for antimicrobial sensitivity, and how does it help in treatment decisions?
The Uniscept™ Manual Antimicrobial Susceptibility Test System is designed to evaluate bacterial isolates against a range of antibiotics, helping clinicians determine which antimicrobial agents will be most effective against specific infections. By identifying bacterial sensitivity patterns, it aids in selecting appropriate treatment regimens for infectious diseases, reducing trial-and-error prescribing and improving patient outcomes.
Is the Uniscept™ system intended for single-use or repeated use in a clinical lab, and what does this mean for cost management?
The Uniscept™ system is supplied as a manual test kit and requires sterile components for accurate results, which implies it is intended for single-use per test. This design ensures reliability and reduces cross-contamination risks, but labs should account for ongoing supply costs as each test requires a new kit. The system is optimized for routine microbiological testing in clinical labs, where frequent testing is standard.
How is the Uniscept™ system regulated by the FDA, and what does this mean for laboratories using it?
The Uniscept™ system is regulated under the FDA’s Premarket Approval (PMA) process, with PMA number P830028. This classification (Class II) ensures it meets stringent standards for antimicrobial susceptibility testing, providing confidence in its accuracy and reliability for clinical decision-making. Laboratories using it must adhere to FDA guidelines for microbiological testing, including proper handling and documentation, as the system is intended exclusively for use in clinical microbiology labs.
What product codes (e.g., JWY) correspond to the Uniscept™ system, and how do they relate to its regulatory compliance?
The Uniscept™ system is distributed under product code JWY, which aligns with FDA’s classification for manual antimicrobial susceptibility test systems (device class 2, regulation number 866.1640). This code ensures the system meets the specific requirements for microbiological testing, including sterility and performance standards, while also facilitating proper inventory and compliance tracking in laboratories.